Related references
Note: Only part of the references are listed.Therapeutic host-directed strategies to improve outcome in tuberculosis
C. Young et al.
MUCOSAL IMMUNOLOGY (2020)
Patient outcomes associated with post-tuberculosis lung damage in Malawi: a prospective cohort study
Jamilah Meghji et al.
THORAX (2020)
TNF-α antagonists differentially induce TGF-β1-dependent resuscitation of dormant-like Mycobacterium tuberculosis
Ainhoa Arbues et al.
PLOS PATHOGENS (2020)
Myeloid-Derived Suppressor Cells as Target of Phosphodiesterase-5 Inhibitors in Host-Directed Therapeutics for Tuberculosis
Vinzeigh Leukes et al.
FRONTIERS IN IMMUNOLOGY (2020)
Tasquinimod targets suppressive myeloid cells in the tumor microenvironment
Li Shen et al.
ONCOIMMUNOLOGY (2019)
Matrix Metalloproteinase Inhibition in a Murine Model of Cavitary Tuberculosis Paradoxically Worsens Pathology
Alvaro A. Ordonez et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Matrix metalloproteinases: Expression, regulation and role in the immunopathology of tuberculosis
Naveed Sabir et al.
CELL PROLIFERATION (2019)
Recent advances with Treg depleting fusion protein toxins for cancer immunotherapy
Pankaj Kumar et al.
IMMUNOTHERAPY (2019)
Assessment of lung function in successfully treated tuberculosis reveals high burden of ventilatory defects and COPD
Akshay N. Gupte et al.
PLOS ONE (2019)
Anti-CTLA-4 Activates Intratumoral NK Cells and Combined with IL15/IL15Rα Complexes Enhances Tumor Control
Emilio Sanseviero et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Regulatory T Cells in Mycobacterium tuberculosis Infection
Paula Cardona et al.
FRONTIERS IN IMMUNOLOGY (2019)
Immune Response to Mycobacterium tuberculosis: A Narrative Review
Maurizio de Martino et al.
FRONTIERS IN PEDIATRICS (2019)
The Role of PARPs in Inflammation-And Metabolic-Related Diseases: Molecular Mechanisms and Beyond
Yueshuang Ke et al.
CELLS (2019)
The Rebirth of Matrix Metalloproteinase Inhibitors: Moving Beyond the Dogma
Gregg B. Fields
CELLS (2019)
Treatment of Drug-Resistant Tuberculosis An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline
Payam Nahid et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Pharmacologic Exhaustion of Suppressor Cells with Tasquinimod Enhances Bacterial Clearance during Tuberculosis
Shashank Gupta et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2019)
Tuberculosis following PD-1 blockade for cancer immunotherapy
Daniel L. Barber et al.
SCIENCE TRANSLATIONAL MEDICINE (2019)
Therapeutic effects of curcumin in inflammatory and immune-mediated diseases: A nature-made jack-of-all-trades?
Elham Abdollahi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
All-trans Retinoic Acid Augments Autophagy during Intracellular Bacterial Infection
Michelle M. Coleman et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)
Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
Lifeng Li et al.
CANCER RESEARCH (2018)
Repetitive Aerosol Exposure Promotes Cavitary Tuberculosis and Enables Screening for Targeted Inhibitors of Extensive Lung Destruction
Michael E. Urbanowski et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Adjunct antibody administration with standard treatment reduces relapse rates in a murine tuberculosis model of necrotic granulomas
Alvaro A. Ordonez et al.
PLOS ONE (2018)
NAD(+) analog reveals PARP-1 substrate-blocking mechanism and allosteric communication from catalytic center to DNA-binding domains
Marie-France Langelier et al.
NATURE COMMUNICATIONS (2018)
Matrix metalloproteinase inhibitors enhance the efficacy of frontline drugs against Mycobacterium tuberculosis
Yitian Xu et al.
PLOS PATHOGENS (2018)
Metformin blocks myeloid-derived suppressor cell accumulation through AMPK-DACH1-CXCL1 axis
Guohui Qin et al.
ONCOIMMUNOLOGY (2018)
Dynamic balance of pro- and anti-inflammatory signals controls disease and limits pathology
Joseph M. Cicchese et al.
IMMUNOLOGICAL REVIEWS (2018)
Mycobacterium tuberculosis Virulent Factor ESAT-6 Drives Macrophage Differentiation Toward the Pro-inflammatory M1 Phenotype and Subsequently Switches It to the Anti-inflammatory M2 Phenotype
Amira Refai et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Translational Potential of Therapeutics Targeting Regulatory Myeloid Cells in Tuberculosis
Nelita du Plessis et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2018)
Old Drugs and New Targets as an Outlook for the Treatment of Tuberculosis
Jan Zitko et al.
CURRENT MEDICINAL CHEMISTRY (2018)
Metformin Use Reverses the Increased Mortality Associated With Diabetes Mellitus During Tuberculosis Treatment
Nicholas R. Degner et al.
CLINICAL INFECTIOUS DISEASES (2018)
International research and guidelines on post-tuberculosis chronic lung disorders: a systematic scoping review
Sanne C. van Kampen et al.
BMJ GLOBAL HEALTH (2018)
Tuberculosis and lung damage: from epidemiology to pathophysiology
Shruthi Ravimohan et al.
EUROPEAN RESPIRATORY REVIEW (2018)
Pulmonary Rehabilitation in Patients with Chronic Lung Impairment from Pulmonary Tuberculosis
Seema K. Singh et al.
CUREUS JOURNAL OF MEDICAL SCIENCE (2018)
Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases
Nathan A. Berger et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Immunotherapy Added to Antibiotic Treatment Reduces Relapse of Disease in a Mouse Model of Tuberculosis
Bas C. Mourik et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2017)
Structural Basis for Potency and Promiscuity in Poly(ADP-ribose) Polymerase (PARP) and Tankyrase Inhibitors
Ann-Gerd Thorsell et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors
Frederick Arce Vargas et al.
IMMUNITY (2017)
Impairment of the pulmonary function after treatment for tuberculosis: the final result of the disease?
Mikhail Ivanovich Chushkin et al.
JORNAL BRASILEIRO DE PNEUMOLOGIA (2017)
Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis
Shashank Gupta et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Inhibition of Tissue Matrix Metalloproteinases Interferes with Mycobacterium tuberculosis-Induced Granuloma Formation and Reduces Bacterial Load in a Human Lung Tissue Model
Venkata R. Parasa et al.
FRONTIERS IN MICROBIOLOGY (2017)
Nanoparticle-Formulated Curcumin Prevents Posttherapeutic Disease Reactivation and Reinfection with Mycobacterium tuberculosis following Isoniazid Therapy
Sultan Tousif et al.
FRONTIERS IN IMMUNOLOGY (2017)
Metformin Adjunctive Therapy Does Not Improve the Sterilizing Activity of the First-Line Antitubercular Regimen in Mice
Noton K. Dutta et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
Role of PARP-1 as a novel transcriptional regulator of MMP-9 in diabetic retinopathy
Manish Mishra et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2017)
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis
Payam Nahid et al.
CLINICAL INFECTIOUS DISEASES (2016)
Anti-PD-1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
Thanyanan Reungwetwattana et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Anti-PD1 Antibody Treatment and the Development of Acute Pulmonary Tuberculosis
Kohei Fujita et al.
JOURNAL OF THORACIC ONCOLOGY (2016)
Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure
Stephanus T. Malherbe et al.
NATURE MEDICINE (2016)
PARP-1 depletion in combination with carbon ion exposure significantly reduces MMPs activity and overall increases TIMPs expression in cultured HeLa cells
Atanu Ghorai et al.
RADIATION ONCOLOGY (2016)
Curcumin enhances human macrophage control of Mycobacterium tuberculosis infection
Xiyuan Bai et al.
RESPIROLOGY (2016)
Lung functions among patients with pulmonary tuberculosis in Dar es Salaam - a cross-sectional study
Mohamed Manji et al.
BMC PULMONARY MEDICINE (2016)
Matrix Metalloproteinases in Tuberculosis-Immune Reconstitution Inflammatory Syndrome and Impaired Lung Function Among Advanced HIV/TB Co-infected Patients Initiating Antiretroviral Therapy
Shruthi Ravimohan et al.
EBIOMEDICINE (2016)
Adjunctive Phosphodiesterase-4 Inhibitor Therapy Improves Antibiotic Response to Pulmonary Tuberculosis in a Rabbit Model
Selvakumar Subbian et al.
EBIOMEDICINE (2016)
Neutrophils and the S100A9 protein critically regulate granuloma formation
Yuya Yoshioka et al.
BLOOD ADVANCES (2016)
Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
Thomas Condamine et al.
ANNUAL REVIEW OF MEDICINE, VOL 66 (2015)
Roflumilast, a Type 4 Phosphodiesterase Inhibitor, Shows Promising Adjunctive, Host-Directed Therapeutic Activity in a Mouse Model of Tuberculosis
Mariama C. Maiga et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
NF-κB transcriptional activation by TNFα requires phospholipase C, extracellular signal-regulated kinase 2 and poly(ADP-ribose) polymerase-1
Billy Vuong et al.
JOURNAL OF NEUROINFLAMMATION (2015)
The role of TIMPs in regulation of extracellular matrix proteolysis
Valerie Arpino et al.
MATRIX BIOLOGY (2015)
Neutrophil-Derived MMP-8 Drives AMPK-Dependent Matrix Destruction in Human Pulmonary Tuberculosis
Catherine W. M. Ong et al.
PLOS PATHOGENS (2015)
Mycobacterium tuberculosis dysregulates MMP/TIMP balance to drive rapid cavitation and unrestrained bacterial proliferation
Andre Kuebler et al.
JOURNAL OF PATHOLOGY (2015)
Mycobacterium tuberculosis-Induced Polarization of Human Macrophage Orchestrates the Formation and Development of Tuberculous Granulomas In Vitro
Zikun Huang et al.
PLOS ONE (2015)
Lung-Residing Myeloid-derived Suppressors Display Dual Functionality in Murine Pulmonary Tuberculosis
Julia K. Knaul et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
Gr-1dimCD11b+ Immature Myeloid-Derived Suppressor Cells but Not Neutrophils Are Markers of Lethal Tuberculosis Infection in Mice
Evgeny N. Tsiganov et al.
JOURNAL OF IMMUNOLOGY (2014)
All-Trans Retinoic Acid-Triggered Antimicrobial Activity against Mycobacterium tuberculosis Is Dependent on NPC2
Matthew Wheelwright et al.
JOURNAL OF IMMUNOLOGY (2014)
Etanercept Exacerbates Inflammation and Pathology in a Rabbit Model of Active Pulmonary Tuberculosis
Liana Tsenova et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2014)
Prednisolone and Mycobacterium indicus pranii in Tuberculous Pericarditis
B. M. Mayosi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Metformin as adjunct antituberculosis therapy
Amit Singhal et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Corticosteroid Effects on Sputum Culture in Pulmonary Tuberculosis: A Meta-Regression Analysis
Robert S. Wallis
OPEN FORUM INFECTIOUS DISEASES (2014)
Increased Frequency of Myeloid-derived Suppressor Cells during Active Tuberculosis and after Recent Mycobacterium tuberculosis Infection Suppresses T-Cell Function
Nelita du Plessis et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
Beyond DNA repair, the immunological role of PARP-1 and its siblings
Maria Manuela Rosado et al.
IMMUNOLOGY (2013)
Adjuvant Host-Directed Therapy with Types 3 and 5 but Not Type 4 Phosphodiesterase Inhibitors Shortens the Duration of Tuberculosis Treatment
Mamoudou Maiga et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond
Nicola J. Curtin et al.
MOLECULAR ASPECTS OF MEDICINE (2013)
Corticosteroids for prevention of mortality in people with tuberculosis: a systematic review and meta-analysis
Julia A. Critchley et al.
LANCET INFECTIOUS DISEASES (2013)
Induced Sputum MMP-1,-3 &-8 Concentrations during Treatment of Tuberculosis
Cesar A. Ugarte-Gil et al.
PLOS ONE (2013)
A review of tasquinimod in the treatment of advanced prostate cancer
Stuart Charles Williamson et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2013)
PARP-1: Friend or Foe of DNA Damage and Repair in Tumorigenesis?
Amanda Swindall et al.
Cancers (2013)
Doxycycline and HIV Infection Suppress Tuberculosis-induced Matrix Metalloproteinases
Naomi F. Walker et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Role of poly(ADP-ribose) polymerases in the regulation of inflammatory processes
Peter Bai et al.
FEBS LETTERS (2012)
Lipopolysaccharide activates ERK-PARP-1-Re1A pathway and promotes nuclear factor-κB transcription in murine macrophages
Linlin Liu et al.
HUMAN IMMUNOLOGY (2012)
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
Bryan A. Gibson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model
Mamoudou Maiga et al.
PLOS ONE (2012)
Adjunctive TNF Inhibition with Standard Treatment Enhances Bacterial Clearance in a Murine Model of Necrotic TB Granulomas
Ciaran Skerry et al.
PLOS ONE (2012)
Signaling Mechanism of Poly(ADP-Ribose) Polymerase-1 (PARP-1) in Inflammatory Diseases
Xueqing Ba et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Genetic variability in the IL1RN gene and the balance between interleukin (IL)-1 receptor agonist and IL-1β in idiopathic pulmonary fibrosis
N. P. Barlo et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2011)
A delicate dance: host response to mycobacteria
Kassidy K. Huynh et al.
CURRENT OPINION IN IMMUNOLOGY (2011)
MMP-1 drives immunopathology in human tuberculosis and transgenic mice
Paul Elkington et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Integrating mechanisms of pulmonary fibrosis
Thomas A. Wynn
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
PARP inhibitors: New tools to protect from inflammation
Vincenzo Giansanti et al.
BIOCHEMICAL PHARMACOLOGY (2010)
Association of Reduced Tumor Necrosis Factor Alpha, Gamma Interferon, and Interleukin-1β (IL-1β) but Increased IL-10 Expression with Improved Chest Radiography in Patients with Pulmonary Tuberculosis
Wen-Lin Su et al.
CLINICAL AND VACCINE IMMUNOLOGY (2010)
Transient role of CD4+CD25+ regulatory T cells in mycobacterial infection in mice
Yuriko Ozeki et al.
INTERNATIONAL IMMUNOLOGY (2010)
CD4+ Regulatory T Cells in a Cynomolgus Macaque Model of Mycobacterium tuberculosis Infection
Angela M. Green et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Inhibition of matrix metalloproteinase-2 by PARP inhibitors
Adrian C. Nicolescu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Adalimumab Treatment of Life-Threatening Tuberculosis
Robert S. Wallis et al.
CLINICAL INFECTIOUS DISEASES (2009)
Parthanatos, a messenger of death
Karen Kate David et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Interleukin-10 promotes Mycobacterium tuberculosis disease progression in CBA/J mice
Gillian L. Beamer et al.
JOURNAL OF IMMUNOLOGY (2008)
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
Graeme Meintjes et al.
LANCET INFECTIOUS DISEASES (2008)
Mechanism of all-trans retinoic acid effect on tumor-associated myeloid-derived suppressor cells
Yulia Nefedova et al.
CANCER RESEARCH (2007)
Synergistic up-regulation of epithelial cell matrix metalloproteinase-9 secretion in tuberculosis
Paul T. Elkington et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2007)
Identification of a new subset of myeloid suppressor cells in peripheral blood of melanoma patients with modulation by a granulocyte-macrophage colony-stimulation factor based antitumor vaccine
Paola Filipazzi et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
CD4(+)CD25(+)FoxP3(+) regulatory T cells suppress Mycobacterium tuberculosis immunity in patients with active disease
Xinchun Chen et al.
CLINICAL IMMUNOLOGY (2007)
Mycobacterium tuberculosis up-regulates matrix metalloproteinase-1 secretion from human airway epithelial cells via a p38 MAPK switch
PTG Elkington et al.
JOURNAL OF IMMUNOLOGY (2005)
Arginase-producing myeloid suppressor cells in renal cell carcinoma patients: A mechanism of tumor evasion
AH Zea et al.
CANCER RESEARCH (2005)
A study of the safety, immunology, virology, and microbiology of adjunctive etanercept in HIV-1-associated tuberculosis
RS Wallis et al.
AIDS (2004)
Activation of poly(ADP-ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation
L Liaudet et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Increased production of immature myeloid cells in cancer patients: A mechanism of immunosuppression in cancer
B Almand et al.
JOURNAL OF IMMUNOLOGY (2001)
Share Paper
